The class XIV myosin of Toxoplasma gondii, TgMyoA, is druggable in an animal model of infection
A. Kelsen, R. S. Kent, A. K. Snyder…·G. E. Ward
This paper identifies KNX-002 as a specific inhibitor of TgMyoA, reducing parasite motility and disease progression in mice.